Results 51 to 60 of about 9,878 (194)

High Prevalence and Clinical Impact of Fibromyalgia in Functional Motor Disorder

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Fibromyalgia is characterized by widespread pain, fatigue, sleep and cognitive symptoms. It overlaps clinically with functional motor disorder (FMD), yet its prevalence and impact in FMD remain uncertain. Objective To determine the prevalence of fibromyalgia in FMD using the current criteria and evaluate its effects on motor ...
Tereza Serranová, Lucia Nováková, Martin Jirásek, Barbora Křupková, Evžen Růžička, Michele Tinazzi, Tomáš Sieger   +6 more
wiley   +1 more source

PENERAPAN ALGORITMA ECLAT UNTUK MENEMUKAN ADVERSE EVENT OBAT ANTIDEPRESAN GOLONGAN SNRI [PDF]

, 2017
Depresi merupakan penyakit gangguan mental yang menempati peringkat ke 4 di dunia. Pengobatan depresi dapat dilakukan melalui pemberian obat antidepresan.
YOSSY SURYANI
core  

Concomitant use of triptan, and SSRI or SNRI after the US food and drug administration alert on serotonin syndrome

, 2012
Objective. The present study was designed to discern the prevalence of concomitant use of a 5-hydroxytryptamine receptor agonist (triptan), and a selective serotonin reuptake inhibitor (SSRI) or a selective serotonin/norepinephrine reuptake inhibitor ...
Schmidt, Jennifer M., Oganov, Ambartsum M., Skaer, Tracy L., Bowen, Kurt A., Robison, M., Kogut, Stephen J., Sclar, David A., Castillo, Leigh V.   +7 more
core   +1 more source

喉頭異常感症に対するボノプラザンフマル酸塩とSNRIの効果 : GETS-J(日本語版GETS)を用いた評価 [PDF]

, 2021
新潟大学Niigata University博士（医学）Purpose To determine patients with abnormal sensation in the throat (AST) who would respond to potassium-competitive acid blocker (P-CAB) or serotonin noradrenaline reuptake inhibitor (SNRI) treatment.
Takahashi, Nao, 高橋, 奈央
core  

Auka SSRI- og SNRI geðdeyfðarlyf blæðingu eftir kransæðahjáveituaðgerð?

, 2018
Inngangur: Þunglyndi er algengt vandamál hjá sjúklingum sem gangast undir kransæða-hjáveituaðgerð. SSRI (selective serotonin reuptake inhibitors) og SNRI (serotonin noradrenaline reuptake inhibitors) geðdeyfðarlyf eru algengastu lyfin sem beitt er við ...
Alexandra Aldís Heimisdóttir 1994-
core   +1 more source

Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder

Brain and Behavior, 2021
Objective To compare the effectiveness and tolerability of agomelatine with mirtazapine in patients with depressive disorder. To illustrate the prescribing pattern of agomelatine and identify factors that affect the pattern of treatment result and ...
Shek Ming Leung
doaj   +1 more source

Anton Valavanis, a Leader in Swiss Neuroscience

Clinical and Translational Neuroscience, 2023
Professor Anton Valavanis [...]
Luca Remonda, Isabel Wanke, Karl-Olof Lövblad, Harald Grossmann, Claudio L. A. Bassetti   +4 more
doaj   +1 more source

Living with the Unknown: Intolerance of Uncertainty in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is marked by pervasive uncertainty due to fluctuating motor and non‐motor symptoms, variable treatment response, and an unpredictable clinical course. Intolerance of uncertainty (IU), a tendency to perceive ambiguity as threatening and respond with worry, avoidance, or decisional paralysis, may be ...
Bradley McDaniels, Gregory M. Pontone, Kuhan Pushparatnam, Indu Subramanian   +3 more
wiley   +1 more source

Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis

, 2022
To assess the efficacy and safety of selective serotonin reuptake inhibitors (SSRIs) and selective noradrenaline reuptake inhibitors (SNRIs) in comparison with various control contingencies (e.g.
Íris Harpa Stefánsdóttir (12568026), Tord Ivarsson (8622681), Gudmundur Skarphedinsson (8622687)   +2 more
core   +1 more source

Factors Associated With Non‐Vasomotor Menopause Symptoms Experienced by 7285 Women: A UK‐Wide National Survey

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To investigate the factors associated with non‐vasomotor menopause symptoms among women in the UK, focusing on the perceived importance of specific symptoms and their association with demographic and treatment‐related factors. Design A cross‐sectional online survey.
Rhianna Davies, Ashwin Goyal, Zachary Nash, Sarah Hillman, Melanie Davies, Nick Panay, Jane Daniels, Tim Hillard, Bonnie Grant, Paula Briggs, Lynne Robinson, Haitham Hamoda, Channa N. Jayasena   +12 more
wiley   +1 more source